- Forums
- ASX - By Stock
- DXB
- Ann: FDA IND Approval for Phase 3 Study of DMX-200 in FSGS
Ann: FDA IND Approval for Phase 3 Study of DMX-200 in FSGS, page-42
-
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DXB (ASX) to my watchlist
|
|||||
Last
49.0¢ |
Change
-0.035(6.67%) |
Mkt cap ! $280.5M |
Open | High | Low | Value | Volume |
52.0¢ | 52.0¢ | 49.0¢ | $1.367M | 2.714M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 49885 | 49.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
49.5¢ | 71264 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
12 | 139251 | 0.495 |
19 | 322388 | 0.490 |
14 | 335468 | 0.485 |
13 | 836396 | 0.480 |
4 | 59155 | 0.475 |
Price($) | Vol. | No. |
---|---|---|
0.500 | 108481 | 12 |
0.505 | 47433 | 6 |
0.510 | 50607 | 4 |
0.515 | 86711 | 5 |
0.520 | 139854 | 7 |
Last trade - 13.07pm 03/07/2024 (20 minute delay) ? |
Featured News
DXB (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online